Tag Archive for: Funding

£1 Billion Boost for UK Life Sciences

New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…

Azeria Therapeutics announces £32.0 million series B financing

Syncona leads £32.0 million Series B financing of Azeria Therapeutics with a £29.5 million commitment Opportunity to address a significant unmet need in oestrogen receptor positive breast cancer patients in lead programme and to build a world class pioneer factor oncology company  London, 21 November 2019 – Azeria Therapeutics (Azeria), a newly formed pioneer factor […]

© Optimum Strategic Communications.